MedPath
NMPA Approval

Doxazosin Mesylate Tablets

国药准字H20031084

June 15, 2020

Drug Information

甲磺酸多沙唑嗪片

史克金康

片剂

2mg

化学药品

June 15, 2020

Company Information

Applicant Company

海南省海口市秀英区南海大道266号国家高新区孵化大楼四楼B3室-A2

Manufacturing Company

明光市工业园洪武大道6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸多沙唑嗪片 - NMPA 批准文号 | MedPath